Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.

Saved in:
Bibliographic Details
Title: Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.
Authors: Mina R; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 1365 Clifton Rd N E, Atlanta, GA, 30322, USA. rmina2@emory.edu.; The Myeloma Unit, Division of Hematology, University of Turin and Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy. rmina2@emory.edu., Mylin AK; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Yokoyama H; Tohoku University Graduate School of Medicine, Sendai, Japan., Magen H; Ramat-Gan, Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel., Alsdorf W; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Shune L; The University of Kansas Medical Center, Kansas City, KS, USA., Isufi I; Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA., Harrison SJ; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Sir Peter MacCallum Dep of Oncology, University of Melbourne, Parkville, Australia., Shah UA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., De Champlain A; Johnson & Johnson, Horsham, PA, USA., Katz EG; Johnson & Johnson, Raritan, NJ, USA., Gries KS; Johnson & Johnson, Raritan, NJ, USA., Schecter JM; Johnson & Johnson, Raritan, NJ, USA., Lendvai N; Johnson & Johnson, Raritan, NJ, USA., Slaughter A; Cilag GmbH International, Zug, Switzerland., Lonardi C; Johnson & Johnson, Buenos Aires, Argentina., Deraedt W; Johnson & Johnson, Beerse, Belgium., Costa Filho O; Legend Biotech USA Inc., Somerset, NJ, USA., Patel N; Legend Biotech USA Inc., Somerset, NJ, USA., Florendo E; Legend Biotech USA Inc., Somerset, NJ, USA., Ho KF; STAT-TU Inc, Elora, ON, Canada., Karlin L; Centre Hospitalier Lyon Sud, Pierre- Bénite, France., Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Source: Journal of patient-reported outcomes [J Patient Rep Outcomes] 2026 Mar 13; Vol. 10 (1). Date of Electronic Publication: 2026 Mar 13.
Publication Type: Journal Article; Clinical Trial, Phase III; Validation Study
Journal Info: Publisher: Springer International Publishing Country of Publication: Germany NLM ID: 101722688 Publication Model: Electronic Cited Medium: Internet ISSN: 2509-8020 (Electronic) Linking ISSN: 25098020 NLM ISO Abbreviation: J Patient Rep Outcomes Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41824255
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mina+R%22">Mina R</searchLink>; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 1365 Clifton Rd N E, Atlanta, GA, 30322, USA. rmina2@emory.edu.; The Myeloma Unit, Division of Hematology, University of Turin and Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy. rmina2@emory.edu.<br /><searchLink fieldCode="AU" term="%22Mylin+AK%22">Mylin AK</searchLink>; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Yokoyama+H%22">Yokoyama H</searchLink>; Tohoku University Graduate School of Medicine, Sendai, Japan.<br /><searchLink fieldCode="AU" term="%22Magen+H%22">Magen H</searchLink>; Ramat-Gan, Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Alsdorf+W%22">Alsdorf W</searchLink>; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Shune+L%22">Shune L</searchLink>; The University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Isufi+I%22">Isufi I</searchLink>; Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Harrison+SJ%22">Harrison SJ</searchLink>; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Sir Peter MacCallum Dep of Oncology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Shah+UA%22">Shah UA</searchLink>; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22De+Champlain+A%22">De Champlain A</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Katz+EG%22">Katz EG</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Gries+KS%22">Gries KS</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Schecter+JM%22">Schecter JM</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lendvai+N%22">Lendvai N</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Slaughter+A%22">Slaughter A</searchLink>; Cilag GmbH International, Zug, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lonardi+C%22">Lonardi C</searchLink>; Johnson & Johnson, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Deraedt+W%22">Deraedt W</searchLink>; Johnson & Johnson, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Costa+Filho+O%22">Costa Filho O</searchLink>; Legend Biotech USA Inc., Somerset, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Patel+N%22">Patel N</searchLink>; Legend Biotech USA Inc., Somerset, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Florendo+E%22">Florendo E</searchLink>; Legend Biotech USA Inc., Somerset, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Ho+KF%22">Ho KF</searchLink>; STAT-TU Inc, Elora, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Karlin+L%22">Karlin L</searchLink>; Centre Hospitalier Lyon Sud, Pierre- Bénite, France.<br /><searchLink fieldCode="AU" term="%22Weisel+K%22">Weisel K</searchLink>; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101722688%22">Journal of patient-reported outcomes</searchLink> [J Patient Rep Outcomes] 2026 Mar 13; Vol. 10 (1). <i>Date of Electronic Publication: </i>2026 Mar 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Validation Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing%22">Springer International Publishing </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101722688 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2509-8020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225098020%22">25098020 </searchLink><i>NLM ISO Abbreviation: </i>J Patient Rep Outcomes <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41824255
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s41687-026-01034-z
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mina R
      – PersonEntity:
          Name:
            NameFull: Mylin AK
      – PersonEntity:
          Name:
            NameFull: Yokoyama H
      – PersonEntity:
          Name:
            NameFull: Magen H
      – PersonEntity:
          Name:
            NameFull: Alsdorf W
      – PersonEntity:
          Name:
            NameFull: Shune L
      – PersonEntity:
          Name:
            NameFull: Isufi I
      – PersonEntity:
          Name:
            NameFull: Harrison SJ
      – PersonEntity:
          Name:
            NameFull: Shah UA
      – PersonEntity:
          Name:
            NameFull: De Champlain A
      – PersonEntity:
          Name:
            NameFull: Katz EG
      – PersonEntity:
          Name:
            NameFull: Gries KS
      – PersonEntity:
          Name:
            NameFull: Schecter JM
      – PersonEntity:
          Name:
            NameFull: Lendvai N
      – PersonEntity:
          Name:
            NameFull: Slaughter A
      – PersonEntity:
          Name:
            NameFull: Lonardi C
      – PersonEntity:
          Name:
            NameFull: Deraedt W
      – PersonEntity:
          Name:
            NameFull: Costa Filho O
      – PersonEntity:
          Name:
            NameFull: Patel N
      – PersonEntity:
          Name:
            NameFull: Florendo E
      – PersonEntity:
          Name:
            NameFull: Ho KF
      – PersonEntity:
          Name:
            NameFull: Karlin L
      – PersonEntity:
          Name:
            NameFull: Weisel K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 03
              Text: 2026 Mar 13
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2509-8020
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of patient-reported outcomes
              Type: main
ResultId 1